Single dose bacterial vaginosis treatment performs well in phase III trial

ANNAPOLIS, MD. – Women with bacterial vaginosis could soon have an effective oral, single-dose treatment option, if results of a phase III study result in approval by the Food and Drug...

Source: Ob.Gyn. News - August 30, 2016 Category: OBGYN Source Type: research